AstraZeneca sent legal notice to Serum Institute for delay in supply of coviciled vaccine: sources

0
9

AstraZeneca’s Covishield vaccine is getting ready in serum

new Delhi:

AstraZeneca’s Covishield Vaccine Legal notice has been sent to the Serum Institute for the delay in the supply of drugs. Sources say that AstraZeneca has sent a legal notice to the Serum Institute of India for the delay in the supply of Corona vaccine. SEO of Serum Adar Poonawala (Adar Poonawalla) said that the Indian government has banned the large supply of Kovishield to other countries and it is difficult to explain the first claim of India to other countries. In those countries Covid vaccine It is being sold at very high prices.

Also read

The government said on the vaccination of AstraZeneca, keeping an eye on all adverse events

Poonawala has already said that there is already a lot of pressure on the current production capacity of Covishield. Poonawala said that the world needs vaccines and we are prioritizing India’s needs, but we are still facing a supply crisis. The Center said last week that there is no complete restriction on vaccine exports. . Poonawala said that the serum is preparing 6 to 6.5 crore vaccines every month. Till date, 10 crore Kovishield vaccines have been exported to the Central Government and 6 crore vaccines have been exported.

Coronavirus: Expert committee allows trial for third dose of Covaxin

At the same time, Covishield vaccine manufacturer Serum needs about 3000 crores to increase its production. Serum Institute of India (SII) CEO (CEO) Adar Poonawalla gave this information. Poonawalla had earlier said that SII agreed to supply the initial 100 million doses at a significantly discounted rate, but now he said that the company should now have made a bigger profit than this so that the amount would be repaid for production and facilities. Investments can be made and more doses of vaccine can be made available.

Speaking to NewsBust, Poonawala said, “We are supplying the vaccine in the Indian market at a rate of around Rs 150-160 while the average price of the vaccine is around $ 20 (Rs 1,500).” On the request of the Narendra Modi government, we are providing the vaccine at a discounted rate. It is not that we are not making profits but we are not making super profit which is important in terms of re-investment.

LEAVE A REPLY

Please enter your comment!
Please enter your name here